Targeting the Immunoglobulin IGSF9 Enhances Anti-Tumor T Cell Activity and Sensitivity to Anti-PD-1 Immunotherapy

Researchers identified increased expression of the adhesion molecule immunoglobulin superfamily member 9 (IGSF9) in tumor cells and tumor-infiltrating immune cells across multiple cancer types.